Siebold S.N. de Graaf

Acute myeloid leukaemia

Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort

Treatment for myeloid leukaemia of Down syndrome: population‐based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials